Cholinergic/Adrenergic drugs US Medical PG Practice Questions and MCQs
Practice US Medical PG questions for Cholinergic/Adrenergic drugs. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Cholinergic/Adrenergic drugs US Medical PG Question 1: In patients with chronic obstructive pulmonary disease, stimulation of muscarinic acetylcholine receptors results in an increase in mucus secretion, smooth muscle contraction and bronchoconstriction. The end result is an increase in airway resistance. Which of the following pharmacologic agents interferes directly with this pathway?
- A. Epinephrine
- B. Albuterol
- C. Theophylline
- D. Ipratropium (Correct Answer)
- E. Metoprolol
Cholinergic/Adrenergic drugs Explanation: ***Ipratropium***
- **Ipratropium** is an **anticholinergic** agent that blocks muscarinic acetylcholine receptors.
- By blocking these receptors, it **reduces bronchoconstriction**, mucus secretion, and smooth muscle contraction, thus decreasing airway resistance.
*Epinephrine*
- **Epinephrine** is a non-selective **adrenergic agonist** that stimulates both alpha and beta receptors.
- Its effects in the airways are primarily mediated through **beta-2 agonism**, leading to bronchodilation, but it does not directly interfere with muscarinic pathways.
*Albuterol*
- **Albuterol** is a **short-acting beta-2 adrenergic agonist (SABA)**.
- It primarily causes bronchodilation by stimulating beta-2 receptors on airway smooth muscle, independent of the muscarinic pathway.
*Theophylline*
- **Theophylline** is a **methylxanthine** that primarily acts as a non-selective phosphodiesterase inhibitor.
- This leads to increased intracellular **cAMP** and bronchodilation, but it does not directly block muscarinic acetylcholine receptors.
*Metoprolol*
- **Metoprolol** is a **selective beta-1 adrenergic blocker** (beta-blocker).
- Its primary action is on the heart; it has minimal effect on airway beta-2 receptors at therapeutic doses due to its selectivity, and it does not interfere with the muscarinic pathway.
Cholinergic/Adrenergic drugs US Medical PG Question 2: A 32-year-old farmer is brought to the emergency department by his wife. The patient was reportedly anxious, sweaty, and complaining of a headache and chest tightness before losing consciousness on route to the hospital. Which of the following is mechanistically responsible for this patient's symptoms?
- A. Reversible inhibition of acetylcholinesterase
- B. Competitive inhibition of acetylcholine at post-junctional effector sites
- C. Binding of acetylcholine agonists to post-junctional receptors
- D. Irreversible inhibition of acetylcholinesterase (Correct Answer)
- E. Inhibition of presynaptic exocytosis of acetylcholine vesicles
Cholinergic/Adrenergic drugs Explanation: ***Irreversible inhibition of acetylcholinesterase***
- The farmer's symptoms (anxiety, sweating, headache, chest tightness, loss of consciousness) are characteristic of **organophosphate poisoning**, which causes a cholinergic crisis due to accumulation of acetylcholine.
- Organophosphates are common in **pesticides** and act by irreversibly inhibiting **acetylcholinesterase**, leading to prolonged stimulation of cholinergic receptors.
*Reversible inhibition of acetylcholinesterase*
- Reversible acetylcholinesterase inhibitors, such as **physostigmine** or **neostigmine**, typically have a shorter duration of action and might cause similar symptoms but are less likely to lead to such severe, acute presentations in an accidental exposure scenario for a farmer.
- These agents are often used therapeutically and would not typically cause prolonged loss of consciousness in this context unless in very high intentional doses.
*Competitive inhibition of acetylcholine at post-junctional effector sites*
- This mechanism describes the action of **anticholinergic drugs** (e.g., atropine), which would block acetylcholine's effects and cause symptoms like dry mouth, dilated pupils, and tachycardia, opposite to what is observed here.
- Such agents would alleviate, not cause, the cholinergic symptoms seen in this patient.
*Binding of acetylcholine agonists to post-junctional receptors*
- While direct agonists (e.g., pilocarpine, methacholine) would mimic acetylcholine and cause cholinergic symptoms, organophosphate poisoning operates by preventing acetylcholine breakdown, rather than directly binding as an exogenous agonist.
- The context of a farmer and sudden, severe symptoms points more strongly to pesticide exposure and acetylcholinesterase inhibition.
*Inhibition of presynaptic exocytosis of acetylcholine vesicles*
- This mechanism is characteristic of **botulinum toxin**, which blocks the release of acetylcholine from presynaptic terminals, leading to muscle paralysis and weakness.
- The patient's symptoms are those of cholinergic excess, not cholinergic blockade or deficiency at the neuromuscular junction.
Cholinergic/Adrenergic drugs US Medical PG Question 3: A 43-year-old man is brought to the emergency department by his wife because of a 1-hour history of confusion and strange behavior. She reports that he started behaving in an agitated manner shortly after eating some wild berries that they had picked during their camping trip. His temperature is 38.7°C (101.7°F). Physical examination shows warm, dry skin and dry mucous membranes. His pupils are dilated and minimally reactive to light. His bowel sounds are decreased. The patient is admitted and pharmacotherapy is initiated with a drug that eventually results in complete resolution of all of his symptoms. This patient was most likely administered which of the following drugs?
- A. Rivastigmine
- B. Atropine
- C. Scopolamine
- D. Physostigmine (Correct Answer)
- E. Neostigmine
Cholinergic/Adrenergic drugs Explanation: ***Physostigmine***
- The patient's symptoms (confusion, agitation, dilated pupils, warm/dry skin, decreased bowel sounds, fever) are characteristic of **anticholinergic toxicity**, often caused by ingestion of plants like Jimson weed or deadly nightshade (containing atropine-like alkaloids).
- **Physostigmine** is a **reversible acetylcholinesterase inhibitor** that can cross the **blood-brain barrier** and reverse both central (confusion, agitation) and peripheral (dilated pupils, dry skin, decreased bowel sounds) anticholinergic effects.
*Rivastigmine*
- **Rivastigmine** is an acetylcholinesterase inhibitor primarily used to treat **Alzheimer's disease** and Parkinson's disease dementia.
- While it inhibits acetylcholinesterase, its primary clinical use and efficacy profile do not align with rapid reversal of acute, severe anticholinergic poisoning.
*Atropine*
- **Atropine** is a **muscarinic anticholinergic agent** that would *exacerbate* the patient's symptoms, as the presentation is consistent with anticholinergic poisoning.
- It works by blocking acetylcholine receptors, leading to effects like dilated pupils, dry mouth, and decreased gastrointestinal motility.
*Scopolamine*
- **Scopolamine** is another potent **muscarinic anticholinergic agent** that causes similar symptoms to atropine, particularly confusion and delirium due to its central nervous system effects.
- Administering scopolamine would worsen the patient's existing anticholinergic toxidrome.
*Neostigmine*
- **Neostigmine** is a **reversible acetylcholinesterase inhibitor** used for conditions like myasthenia gravis and reversal of neuromuscular blockade.
- However, **neostigmine does not cross the blood-brain barrier** effectively, meaning it would not reverse the central nervous system symptoms (confusion, agitation) prominent in this anticholinergic poisoning case.
Cholinergic/Adrenergic drugs US Medical PG Question 4: A 34-year-old female presents to the emergency room with headache and palpitations. She is sweating profusely and appears tremulous on exam. Vital signs are as follows: HR 120, BP 190/110, RR 18, O2 99% on room air, and Temp 37C. Urinary metanephrines and catechols are positive. Which of the following medical regimens is contraindicated as a first-line therapy in this patient?
- A. Labetalol
- B. Propranolol (Correct Answer)
- C. Nitroprusside
- D. Lisinopril
- E. Phenoxybenzamine
Cholinergic/Adrenergic drugs Explanation: ***Propranolol***
- This patient's presentation with headache, palpitations, sweating, hypertension, and tachycardia, along with elevated urinary metanephrines and catechols, is highly suggestive of a **pheochromocytoma**.
- **Pure beta-blockers** (like propranolol) are **absolutely contraindicated** as first-line therapy because blocking $\beta_2$ receptors without initial $\alpha$-blockade leads to unopposed $\alpha$-adrenergic stimulation, causing severe **vasoconstriction** and a dangerous **hypertensive crisis**.
- This is the **most contraindicated** option among the choices listed.
*Labetalol*
- Labetalol is a **non-selective $\beta$-blocker with some $\alpha_1$-blocking activity** (β:α blockade ratio ~7:1).
- While **not recommended** as first-line monotherapy in pheochromocytoma due to predominant beta-blockade, it has **some alpha-blocking properties** that distinguish it from pure beta-blockers.
- In practice, it's typically avoided as initial therapy, but it carries **less risk** than pure beta-blockers because of its partial alpha-blockade.
- Some sources consider it relatively contraindicated, but propranolol (pure beta-blocker) is more definitively contraindicated.
*Nitroprusside*
- **Nitroprusside** is a potent **vasodilator** that acts on both arterial and venous beds, making it effective for **rapid blood pressure reduction** in hypertensive emergencies.
- It is **not contraindicated** and can be used in a pheochromocytoma crisis for acute blood pressure control, though it should ideally be combined with alpha-blockade.
- It does not directly address catecholamine effects but provides symptomatic BP control.
*Lisinopril*
- **Lisinopril** is an **ACE inhibitor**, which works by preventing the conversion of angiotensin I to angiotensin II, leading to vasodilation and reduced aldosterone secretion.
- It is **not contraindicated** but is **inappropriate** as first-line therapy in pheochromocytoma crisis because it does not directly counteract the massive catecholamine release.
- It would be ineffective for managing the acute hypertensive emergency.
*Phenoxybenzamine*
- **Phenoxybenzamine** is an **irreversible, non-selective $\alpha$-adrenergic blocker** that is the **gold standard first-line therapy** for pheochromocytoma.
- It effectively blocks the vasoconstrictive effects of catecholamines, allowing for adequate blood pressure control before any $\beta$-blockade is considered.
- This is the **correct first-line medication**, not contraindicated.
Cholinergic/Adrenergic drugs US Medical PG Question 5: A 55-year-old woman comes to the physician because of involuntary hand movements that improve with alcohol consumption. Physical examination shows bilateral hand tremors that worsen when the patient is asked to extend her arms out in front of her. The physician prescribes a medication that is associated with an increased risk of bronchospasms. This drug has which of the following immediate effects on the cardiovascular system?
Stroke volume | Heart rate | Peripheral vascular resistance
- A. ↓ ↓ ↓
- B. ↓ ↓ ↑ (Correct Answer)
- C. ↓ ↑ ↑
- D. ↑ ↑ ↑
- E. ↑ ↑ ↓
Cholinergic/Adrenergic drugs Explanation: ***↓ ↓ ↑***
- This patient likely has **essential tremor**, which is characterized by **bilateral hand tremors** that improve with alcohol and worsen with intention (postural tremor). The prescribed medication is a **beta-blocker** (e.g., propranolol), which is associated with an increased risk of bronchospasms due to blocking **beta-2 receptors** in the airways.
- Beta-blockers **decrease heart rate** (negative chronotropic effect) and **stroke volume** (negative inotropic effect) by blocking beta-1 receptors in the heart, reducing cardiac output.
- **Peripheral vascular resistance increases** acutely due to: (1) **unopposed alpha-1 adrenergic tone** in blood vessels (loss of beta-2 mediated vasodilation), and (2) baroreceptor-mediated reflex vasoconstriction in response to decreased cardiac output. This helps maintain blood pressure despite reduced cardiac output.
*↓ ↓ ↓*
- While beta-blockers decrease **heart rate** and **stroke volume**, peripheral vascular resistance does not decrease acutely. A decrease in all three parameters would cause severe hypotension.
- The loss of beta-2 receptor-mediated vasodilation and baroreceptor reflexes lead to increased, not decreased, peripheral vascular resistance.
*↓ ↑ ↑*
- Beta-blockers **decrease heart rate** through beta-1 blockade, not increase it. This is their primary cardiac mechanism of action.
- An increase in heart rate would be expected with sympathomimetic drugs or anticholinergics, not beta-blockers.
*↑ ↑ ↑*
- This combination indicates increased cardiovascular activity, which is the opposite effect of **beta-blockers**.
- Beta-blockers reduce heart rate and stroke volume by blocking beta-1 receptors; they do not increase these parameters.
- This pattern would suggest sympathetic activation or administration of an adrenergic agonist.
*↑ ↑ ↓*
- Beta-blockers **decrease** (not increase) both heart rate and stroke volume through beta-1 receptor blockade.
- While decreased peripheral vascular resistance occurs with vasodilators, beta-blockers acutely **increase** PVR due to unopposed alpha-adrenergic tone.
More Cholinergic/Adrenergic drugs US Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
